跳至主要内容
临床试验/NCT00997256
NCT00997256已完成1 期

Phase I, Placebo-controlled, Double-blind, Randomised, Single-centre Study of Single Cross-over Design to Investigate the Effects of the Herbal Preparation Neurapas® Balance Compared With Placebo on Sleep EEG, Mental Performance and Well-being

Pascoe Pharmazeutische Praeparate GmbH1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2004年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Evaluation of sleep by Polysomnography (sleep continuity and sleep architecture)

研究概览

简要总结

To demonstrate the influence of a herbal preparation containing hypericum, passionflower, and valerian on sleep structure, improvement of attention, and well-being in comparison to placebo.

详细描述

To demonstrate the influence of the herbal combination preparation Neurapas® balance on the objective sleep structure in comparison with placebo. A further aim was to investigate whether treatment with Neurapas® balance versus placebo brings about an improvement in attention and well-being and whether these changes are related to the improvement in the sleep structure.

  1. Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days vs. placebo lead to an improvement in continuity of sleep?
  2. Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days vs. placebo lead to an improvement in sleep architecture, especially an increase in deep sleep?
  3. Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days vs. placebo lead to an improvement in morning attentional performance?
  4. Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days vs. placebo lead to an improvement in morning well-being?

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy male volunteers aged between 18 and 55 years
  • Normal sleeping times (at least 6 hours a night), going to sleep between 22.00 and 1.00 hours, getting up between 6.00 and 9.00 hours
  • Written informed consent
  • The volunteer is willing and able to cooperate fully
  • The volunteer agrees not to drink any alcohol for the duration of the study

排除标准

  • Participation in another study in the last 30 days or participation in this study at an earlier date
  • Lack of verbal or intellectual ability to communicate adequately and to understand the information to volunteers
  • Legal incompetence
  • Shift worker
  • Transatlantic flight in the last 4 weeks
  • Taking psychotropic drugs within the last 4 weeks
  • Taking medicines that influence the EEG within the last 4 weeks
  • Diseases that influence the sleep EEG
  • History of known medication / drug / alcohol misuse according to ICD-10 coding F10 - F19
  • Known intolerance/hypersensitivity/allergy to St. John's wort, valerian or passionflower
  • Taking inadmissible concomitant medication (anxiolytic, neuroleptic or hypnotic drugs, cyclosporin, sedative, sleep-promoting or mood-enhancing medicines, antidepressants other than the trial medication, coumarin-type anticoagulants, oral contraceptives, tranquillisers, homeopathic remedies, digoxin, theophylline, indinavir, nortriptyline, amitriptyline)
  • Known light-sensitivity

研究组 & 干预措施

Placebo

Placebo Comparator

Film-coated sugar-pill

干预措施: film-coated sugar-pill (Drug)

Verum

Experimental

Neurapas balance, film-coated tablets

干预措施: Neurapas® balance (Herbal product (Hypericum, Passionflower, Valerian)) (Drug)

结局指标

主要结局

Evaluation of sleep by Polysomnography (sleep continuity and sleep architecture)

时间窗: Day 3 + 14

次要结局

  • Attention Stress Test d2 (Brickenkamp)(Day 4 + 15)
  • Alertness and vigilance test (TAP)(Day 4 + 15)
  • Trail-Making Test (TMT)(Day 4 + 15)
  • Questionnaire on physical symptoms of subjective well-Being(MKSL, Janke)(Day 4 +15)
  • Questionnaire on psychological aspects of well-being(BSKE, Janke)(Day 4 + 15)
  • ZERSSEN Scale of evaluation of subjective well-being (Bf-S)(Day 4 + 15)
  • Sleep Questionnaire(SF)(Day 4 + 15)

研究者

发起方
Pascoe Pharmazeutische Praeparate GmbH
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验